Disrupting Clinical Trials by Innovator Dr. Harsha Rajasimha of Jeeva
Zimmer Biomet Holdings, Inc. (ZBH)
Last zimmer biomet holdings, inc. earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zimmerbiomet.com
Company Research
Source: PR Web
TAMPA BAY, Fla. (PRWEB) September 20, 2021 Today, there are approximately 7,000 rare diseases affecting about 350 million worldwide.(1) That is more than the entire population of the United States. Many of these diseases have no treatments. However, clinical drug and treatment trials stand to prevent much of the immense suffering and death. These trials typically take 5 to 7 years to complete and get a drug or vaccine to market. In contrast, COVID-19 vaccines were developed in a fraction of the usual time – in 5 to 7 months. Enter Disruptor Dr. Harsha Rajasimha, Founder & CEO of Jeeva Informatics Solutions--who explains to Karla Jo Helms, host of the Disruption Interruption podcast--that if we applied the COVID-19 trial's timeline to other diseases, many more vaccines and drugs for even rare diseases could begin helping millions who are now suffering. But right now, 88% of drugs that enter into human clinical trials do not get FDA approval because of the lack of evidence, enrollment
Show less
Read more
Impact Snapshot
Event Time:
ZBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBH alerts
High impacting Zimmer Biomet Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ZBH
News
- Facial Implants Market to Hit Sales of US$ 55 Billion in 2031 Expanding at a CAGR of 3.61%, Predicts Fairfield Market Research [Yahoo! Finance]Yahoo! Finance
- Biomed 2024, Israel's Leading Annual Life Science Conference and Exhibition, May 21-23, in Tel Aviv [Yahoo! Finance]Yahoo! Finance
- Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings. [Yahoo! Finance]Yahoo! Finance
- J&J CFO: We've 'beefed up' cardiovascular medical devices business in hopes of reviving our medtech business [Yahoo! Finance]Yahoo! Finance
- EpiWatch Names Teresa Prego as CEO [Yahoo! Finance]Yahoo! Finance
ZBH
Earnings
- 2/8/24 - Beat
ZBH
Sec Filings
- 4/3/24 - Form 4
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ZBH's page on the SEC website